Table 1.
Association between NB patients’ clinicopathological factors and miR-149 expression
| Clinicopathologic features | N (%) | Relative miR-149 level | P value | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
| Total cases | 42 (100.0) | 15 (35.7) | 27 (64.3) | |
| Age (years) | 0.3526 | |||
| ≥ 2.5 | 24 (57.1) | 10 (41.7) | 14 (58.3) | |
| < 2.5 | 18 (42.9) | 5 (27.8) | 13 (72.2) | |
| Gender | 0.3939 | |||
| Male | 26 (61.9) | 8 (30.8) | 18 (69.2) | |
| Female | 16 (38.1) | 7 (43.8) | 9 (56.2) | |
| INSS stage | 0.0376 | |||
| I–II | 19 (45.2) | 10 (52.6) | 9 (47.4) | |
| III–IV | 23 (54.8) | 5 (21.7) | 18 (78.3) | |
| Lymph node metastasis | 0.0241 | |||
| No | 27 (64.3) | 13 (48.1) | 14 (51.9) | |
| Yes | 15 (35.7) | 2 (13.3) | 13 (86.7) | |
NB neuroblastoma, INSS International Neuroblastoma Staging System